EURO - MEDIC

{
  "events": [
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Philippe Peeters",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Heist-op-den-Berg",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-08-08",
    "filing_date": "2025-07-31",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-11",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2025-05-16"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0473.175.601",
    "name_full": "EURO-MEDIC",
    "legal_form": "naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Philippe Peeters",
    "org_rep_person_name": null,
    "person_role_at_subject": "Notaris"
  },
  "co_filed_documents": [
    "splitsingsvoorstel",
    "verslag van het bestuursorgaan",
    "controleverslag van de bedrijfsrevisor",
    "jaarrekeningen",
    "verslagen van het bestuursorgaan",
    "proposaal tot verzaking aan het opstellen van tussentijdse cijfers"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "SKYPHARMA LIMITED",
      "role": "aandeelhouder",
      "n_shares": 296,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 1346,
      "class_name": "aandelen zonder aanduiding van de nominale waarde",
      "capital_share_eur": 113769.82,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "stage": "completed",
  "notary": {
    "name": "Philippe Peeters",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Heist-op-den-Berg",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-08-08",
    "filing_date": "2025-07-31",
    "act_kind_objet": "PARTI\u00CBLE SPLITSING DOOR OVERNEMING"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-11",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": {
    "summary": "De vennootschap verzakt het verslag van het bestuursorgaan over het splitsingsvoorstel en de beslissing tot verzaking aan dit verslag.",
    "articles": [
      "12:65"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": null,
        "name": "PharmaCross",
        "role": "demerged",
        "address": null,
        "is_foreign": false,
        "legal_form": "BS",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0473.175.601",
        "name": "EURO-MEDIC",
        "role": "acquiring",
        "address": "9800 Deinze, Poeldendries 49",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "SKYPHARMA LIMITED",
        "role": "recipient",
        "address": null,
        "is_foreign": true,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "GB"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:64",
      "12:61",
      "12:62",
      "12:65",
      "7:179",
      "7:197",
      "12:71",
      "12:63",
      "12:69",
      "12:59"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2024-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 296,
    "real_estate_included": true,
    "patrimony_description": "De te splitsen vennootschap overdraagt een deel van haar vermogen aan de overnemende vennootschap, inclusief onroerende goederen zoals appartementen en staanplaatsen.",
    "equity_transferred_eur": 8769.82,
    "accounting_effective_date": "2025-01-01"
  },
  "subject_company": {
    "kbo": "0473.175.601",
    "name_full": "EURO-MEDIC",
    "legal_form": "naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Philippe Peeters",
    "org_rep_person_name": null
  },
  "summary_narrative": "De naamloze vennootschap EURO-MEDIC heeft een buitengewone algemene vergadering gehouden om een parti\u00EBle splitsing te goedkeuren. Hierbij wordt een deel van het vermogen van de besloten vennootschap PharmaCross overgedragen aan EURO-MEDIC. Als vergoeding voor deze inbreng in natura worden 296 aandelen uitgegeven aan de enige aandeelhouder van PharmaCross, SKYPHARMA LIMITED. De overdracht omvat ook onroerende goederen en de boekhoudkundige toewijzing is vanaf 1 januari 2025 voor rekening van de overnemende vennootschap.",
  "co_filed_documents": [
    "een uitgifte"
  ],
  "detected_real_type": "demerger_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-05-27",
    "filing_date": "2025-05-19",
    "act_kind_objet": "Neerlegging voorstel parti\u00EBle splitsing door overneming"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-05-16",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": {
    "summary": "De enige bestuurder stelt voor om te verzaken aan de verslaggevingsverplichting van de bedrijfsrevisor zoals voorzien in artikel 12:62, \u00A71 WWV.",
    "articles": [
      "12:62, \u00A71",
      "7:179 juncto 7:197"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0473.175.601",
        "name": "EURO-MEDIC NV",
        "role": "acquiring",
        "address": "Poeldendries 49, 9850 Deinze",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0888.580.475",
        "name": "PHARMACROSS BV",
        "role": "demerged",
        "address": "Poeldendries 49, 9850 Deinze",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "SKYPHARMA LIMITED",
        "role": "recipient",
        "address": "26 Saint Laurence Street, Drogheda, Louth, A92P5VW",
        "is_foreign": true,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "IE"
      }
    ],
    "exchange_ratio": 2.96,
    "legal_articles": [
      "12:8, 1\u00B0",
      "12:59",
      "12:62, \u00A71",
      "12:62, \u00A72",
      "7:179 juncto 7:197",
      "7:179, \u00A71"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2025-03-31",
    "exchange_ratio_text": "8.664,40 = 2,96",
    "new_shares_issued_n": 296,
    "real_estate_included": true,
    "patrimony_description": "Een aantal activa- en passivabestanddelen van PHARMACROSS BV worden overgedragen naar EURO-MEDIC NV.",
    "equity_transferred_eur": 866439.67,
    "accounting_effective_date": "2025-01-01"
  },
  "subject_company": {
    "kbo": "0473.175.601",
    "name_full": "EURO-MEDIC",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "summary_narrative": "De akte is een voorstel tot parti\u00EBle splitsing door overneming tussen EURO-MEDIC NV en PHARMACROSS BV. Hierbij worden bepaalde activa en passiva van PHARMACROSS BV overgedragen aan EURO-MEDIC NV, waarbij PHARMACROSS BV blijft bestaan. De aandeelhouders van PHARMACROSS BV ontvangen hierbij nieuwe aandelen in EURO-MEDIC NV. De splitsing wordt goedgekeurd door de buitengewone algemene vergadering van aandeelhouders.",
  "co_filed_documents": [],
  "detected_real_type": "demerger_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}